DNA plasmid technology has many applications. My take is Inovio is a good Buy for investors with diverse portfolios who can stand the risk.

GenoFAB Announces Publication of Groundbreaking Self-Documenting Plasmid Technology In Trends In Biotechnology PR Newswire FORT COLLINS, Colo., May 7, 2025 ...

Scientists use plasmids as the leading gene delivery technology for a variety of research and clinical applications related to gene therapy. Traditional approaches to plasmid creation often result in ...

The purification of plasmid DNA (pDNA) is essential in molecular biology research. Over the years, plasmid DNA isolation technology has provided researchers with multiple efficient methods for ...

Inovio reported positive Phase 3 VGX-3100 data. In addition to treating cervical dysplasia, label expansion is likely. DNA plasmid technology is poised to create a broad array of commercial ...

Recently published data demonstrated that plasmid-free technology could produce over tenfold more AAV compared with a transient approach and particles which are 5- to 60-fold more infectious ...

Global $6.7 Billion CRISPR Technology Market Opportunities to 2030: Cas9 And gRNA, Design Tool, Plasmid and Vector, Other Delivery System Products ...

In addition to SnapFast, OXGENE’s technologies include TESSA™, a scalable, plasmid-free adeno-associated virus (AAV) manufacturing system designed to facilitate robust and reproducible AAV ...

Imunon is using preclinical trials to evaluate whether its multivalent DNA plasmid technology, called Placcine, can show superiority to the hugely successful mRNA vaccines for COVID-19 from the ...

Inovio Pharmaceuticals, Inc. INO announced today the publication of a peer-reviewed paper demonstrating the success of its new DNA plasmid technology in generating therapeutic monoclonal ...

"This technology benefits both plasmid developers and users," said Jean Peccoud, lead author and founder of GenoFAB. "The GSIN technology presented in this article will transform the way new ...